Home

Novelix Pharmaceuticals Ltd EPS

Image

Novelix Pharmaceuticals Ltd

NSE: NOVELIX

EPS

₹ -1.5

Last updated on: Sep 01, 2025

Key Highlights

  • The Earning per Share of Novelix Pharmaceuticals Ltd is ₹ -1.5 as of 01 Sep 25 .
  • The earning per share of Novelix Pharmaceuticals Ltd changed from ₹ -0.21 to ₹ 0.37 over 10 quarters. This represents a CAGR of NaN% .

Historical Earning per Share of Novelix Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Novelix Pharmaceuticals Ltd

Market Cap

96 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

3.2

Day’s High

59.75

Day’s Low

59.75

DTE

0.1

ROE

-30.2

52 Week High

70.16

52 Week Low

23.0

ROCE

-32.5

Market Price of Novelix Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Novelix Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Dec 202559.75
03 Dec 202562.89
02 Dec 202566.16
01 Dec 202563.01
28 Nov 202560.01
27 Nov 202557.16
26 Nov 202554.44
25 Nov 202551.85
24 Nov 202554.44
21 Nov 202557.3

SWOT Analysis Of Novelix Pharmaceuticals Ltd

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Novelix Pharmaceuticals Ltd

Asset Value vs Market Value of Novelix Pharmaceuticals Ltd

Market Value

59

Asset Value

Value addition

8.8 X

6

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Novelix Pharmaceuticals Ltd58.64
Sun Pharmaceutical Industries Ltd436343
Divis Laboratories Ltd171774
Torrent Pharmaceuticals Ltd128659
Cipla Ltd122878
Dr Reddys Laboratories Ltd106581

Historical Market Cap of Novelix Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Novelix Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Novelix Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Novelix Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Novelix Pharmaceuticals Ltd News Hub

Trimurthi reports standalone net loss of Rs 0.35 crore in the June 2024 quarter

Net Loss of Trimurthi reported to Rs 0.35 crore in the quarter ended June 2024 as against net loss o

Read more

08 Aug 24

Trimurthi schedules AGM

Trimurthi announced that the Annual General Meeting (AGM) of the company will be held on 27 Septembe

Read more

14 Sept 24

Trimurthi announces board meeting date

Trimurthi will hold a meeting of the Board of Directors of the Company on 2 September 2024. Powered

Read more

24 Aug 24

Trimurthi to announce Quarterly Result

Trimurthi will hold a meeting of the Board of Directors of the Company on 13 November 2024 Powered b

Read more

09 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Novelix Pharmaceuticals Ltd

What is the EPS of Novelix Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Novelix Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Novelix Pharmaceuticals Ltd EPS calculated?

The EPS of Novelix Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Novelix Pharmaceuticals Ltd report its EPS?

Novelix Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Novelix Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Novelix Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Novelix Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Novelix Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions